Literature DB >> 24121126

Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Shannon L Rhodes1, Daniel D Buchanan2, Ismaïl Ahmed3, Kent D Taylor4, Marie-Anne Loriot5, Janet S Sinsheimer6, Jeff M Bronstein7, Alexis Elbaz8, George D Mellick9, Jerome I Rotter4, Beate Ritz10.   

Abstract

Pathologic features of Parkinson's disease (PD) include death of dopaminergic neurons in the substantia nigra, presence of α-synuclein containing Lewy bodies, and iron accumulation in PD-related brain regions. The observed iron accumulation may be contributing to PD etiology but it also may be a byproduct of cell death or cellular dysfunction. To elucidate the possible role of iron accumulation in PD, we investigated genetic variation in 16 genes related to iron homeostasis in three case-control studies from the United States, Australia, and France. After screening 90 haplotype tagging single nucleotide polymorphisms (SNPs) within the genes of interest in the US study population, we investigated the five most promising gene regions in two additional independent case-control studies. For the pooled data set (1289 cases, 1391 controls) we observed a protective association (OR=0.83, 95% CI: 0.71-0.96) between PD and a haplotype composed of the A allele at rs1880669 and the T allele at rs1049296 in transferrin (TF; GeneID: 7018). Additionally, we observed a suggestive protective association (OR=0.87, 95% CI: 0.74-1.02) between PD and a haplotype composed of the G allele at rs10247962 and the A allele at rs4434553 in transferrin receptor 2 (TFR2; GeneID: 7036). We observed no associations in our pooled sample for haplotypes in SLC40A1, CYB561, or HFE. Taken together with previous findings in model systems, our results suggest that TF or a TF-TFR2 complex may have a role in the etiology of PD, possibly through iron misregulation or mitochondrial dysfunction within dopaminergic neurons.
© 2013.

Entities:  

Keywords:  Epidemiology; Genetics; Iron homeostasis; Pooled-analysis; Transferrin; Transferrin receptor 2

Mesh:

Substances:

Year:  2013        PMID: 24121126      PMCID: PMC3968945          DOI: 10.1016/j.nbd.2013.09.019

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  75 in total

1.  Increased nigral iron content in postmortem parkinsonian brain.

Authors:  D T Dexter; F R Wells; F Agid; Y Agid; A J Lees; P Jenner; C D Marsden
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

2.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

3.  Regulation of the 75-kDa subunit of mitochondrial complex I by iron.

Authors:  E Lin; J H Graziano; G A Freyer
Journal:  J Biol Chem       Date:  2001-04-19       Impact factor: 5.157

Review 4.  Iron trafficking inside the brain.

Authors:  Torben Moos; Thomas Rosengren Nielsen; Tina Skjørringe; Evan H Morgan
Journal:  J Neurochem       Date:  2007-10-22       Impact factor: 5.372

5.  The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain.

Authors:  Torben Moos; Evan H Morgan
Journal:  J Neurochem       Date:  2004-01       Impact factor: 5.372

6.  The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients.

Authors:  D D Buchanan; P A Silburn; J B Chalk; D G Le Couteur; G D Mellick
Journal:  Neurosci Lett       Date:  2002-07-19       Impact factor: 3.046

7.  Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?

Authors:  Greg T Sutherland; Glenda M Halliday; Peter A Silburn; Frank L Mastaglia; Dominic B Rowe; Richard S Boyle; John D O'Sullivan; Tina Ly; Steve D Wilton; George D Mellick
Journal:  Mov Disord       Date:  2009-04-30       Impact factor: 10.338

8.  Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys.

Authors:  Yi He; Patricia S Thong; Timothy Lee; S K Leong; Bo Y Mao; Fang Dong; Frank Watt
Journal:  Free Radic Biol Med       Date:  2003-09-01       Impact factor: 7.376

9.  Common variants in TMPRSS6 are associated with iron status and erythrocyte volume.

Authors:  Beben Benyamin; Manuel A R Ferreira; Gonneke Willemsen; Scott Gordon; Rita P S Middelberg; Brian P McEvoy; Jouke-Jan Hottenga; Anjali K Henders; Megan J Campbell; Leanne Wallace; Ian H Frazer; Andrew C Heath; Eco J C de Geus; Dale R Nyholt; Peter M Visscher; Brenda W Penninx; Dorret I Boomsma; Nicholas G Martin; Grant W Montgomery; John B Whitfield
Journal:  Nat Genet       Date:  2009-10-11       Impact factor: 38.330

Review 10.  Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element.

Authors:  David Olivares; Xudong Huang; Lars Branden; Nigel H Greig; Jack T Rogers
Journal:  Int J Mol Sci       Date:  2009-03-17       Impact factor: 5.923

View more
  29 in total

Review 1.  Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress.

Authors:  Carla Garza-Lombó; Yanahi Posadas; Liliana Quintanar; María E Gonsebatt; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

Review 2.  Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Manuj Ahuja; Bobby Thomas
Journal:  Mol Cell Neurosci       Date:  2019-10-20       Impact factor: 4.314

Review 3.  Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  David Devos; Z Ioav Cabantchik; Caroline Moreau; Véronique Danel; Laura Mahoney-Sanchez; Hind Bouchaoui; Flore Gouel; Anne-Sophie Rolland; James A Duce; Jean-Christophe Devedjian
Journal:  J Neural Transm (Vienna)       Date:  2020-01-07       Impact factor: 3.575

4.  Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice.

Authors:  Franziska Richter; Lauryn Gabby; Kimberly A McDowell; Caitlyn K Mulligan; Krystal De La Rosa; Pedrom C Sioshansi; Farzad Mortazavi; Ingrid Cely; Larry C Ackerson; Linda Tsan; Niall P Murphy; Nigel T Maidment; Marie-Françoise Chesselet
Journal:  Neurobiol Aging       Date:  2016-12-01       Impact factor: 4.673

5.  Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson's Disease Incidence.

Authors:  Briana R De Miranda; Marco Fazzari; Emily M Rocha; Sandra Castro; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2019-07-01       Impact factor: 4.849

Review 6.  Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Authors:  Hong Jiang; Jun Wang; Jack Rogers; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

7.  Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.

Authors:  Naying He; Huawei Ling; Bei Ding; Juan Huang; Yong Zhang; Zhongping Zhang; Chunlei Liu; Kemin Chen; Fuhua Yan
Journal:  Hum Brain Mapp       Date:  2015-08-07       Impact factor: 5.038

Review 8.  Iron-sulfur cluster biosynthesis and trafficking - impact on human disease conditions.

Authors:  C Wachnowsky; I Fidai; J A Cowan
Journal:  Metallomics       Date:  2018-01-24       Impact factor: 4.526

Review 9.  Targeting NRF2 to suppress ferroptosis in brain injury.

Authors:  Shunchen Song; Yaxuan Gao; Yi Sheng; Tongyu Rui; Chengliang Luo
Journal:  Histol Histopathol       Date:  2020-11-26       Impact factor: 2.303

Review 10.  Ferroptosis and Its Role in Diverse Brain Diseases.

Authors:  Abigail Weiland; Yamei Wang; Weihua Wu; Xi Lan; Xiaoning Han; Qian Li; Jian Wang
Journal:  Mol Neurobiol       Date:  2018-11-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.